Amedeo Smart

Free Medical Literature Service

 

Amedeo

Hyperlipoproteinemias
  Free Subscription

Articles published in
Circulation
    August 2025
  1. LIU Y, Wang H, Yu M, Cai L, et al
    Hypertriglyceridemia as a Key Contributor to Abdominal Aortic Aneurysm Development and Rupture: Insights From Genetic and Experimental Models.
    Circulation. 2025 Aug 5:10.1161/CIRCULATIONAHA.125.074737.
    >> Share

    July 2025
  2. WIEGMAN A, Greber-Platzer S, Ali S, Doortje Reijman M, et al
    Correction to: Evinacumab for Pediatric Patients With Homozygous Familial Hypercholesterolemia.
    Circulation. 2025;152:e22.
    >> Share

    May 2025
  3. WIEGMAN A, Peterson AL, Hegele RA, Bruckert E, et al
    Efficacy and Safety of Inclisiran in Adolescents With Genetically Confirmed Homozygous Familial Hypercholesterolemia: Results From the Double-Blind, Placebo-Controlled Part of the ORION-13 Randomized Trial.
    Circulation. 2025 May 20. doi: 10.1161/CIRCULATIONAHA.124.073233.
    >> Share

    March 2025
  4. CHUBYKINA U, Vasiluev P, Ivanova O, Ezhov M, et al
    The Mysterious Masks of Hypercholesterolemia: A Unique Clinical Case.
    Circulation. 2025;151:799-803.
    >> Share

    November 2024
  5. LIU J, Bellows BK, Jacobs DR Jr, Woo JG, et al
    Low-Density Lipoprotein Cholesterol Level Distributions Across Different Ages: Implications for Screening Children for Severe and Familial Hypercholesterolemia.
    Circulation. 2024;150:1741-1744.
    >> Share

    August 2024
  6. DAMASE TR, Sukhovershin R, Godin B, Nasir K, et al
    Established and Emerging Nucleic Acid Therapies for Familial Hypercholesterolemia.
    Circulation. 2024;150:724-735.
    >> Share

    April 2024
  7. TAMARGO IA, Baek KI, Xu C, Kang DW, et al
    HEG1 Protects Against Atherosclerosis by Regulating Stable Flow-Induced KLF2/4 Expression in Endothelial Cells.
    Circulation. 2024;149:1183-1201.
    >> Share

    February 2024
  8. STONE NJ, Blum C
    If Action is Delayed, Is Survival Denied? Management of Severe Hypercholesterolemia Is Important and Urgent.
    Circulation. 2024;149:427-429.
    >> Share

    January 2024
  9. SANTOS RD, Cuchel M
    LDL-C-Lowering Therapies for Adults and Children With Homozygous Familial Hypercholesterolemia: Challenges and Successes.
    Circulation. 2024;149:363-366.
    >> Share

    November 2023
  10. YALCINKAYA M, Liu W, Thomas LA, Olszewska M, et al
    BRCC3-Mediated NLRP3 Deubiquitylation Promotes Inflammasome Activation and Atherosclerosis in Tet2 Clonal Hematopoiesis.
    Circulation. 2023;148:1764-1777.
    >> Share

  11. MILES J, Scotti A, Castagna F, Kuno T, et al
    Long-Term Mortality in Patients With Severe Hypercholesterolemia Phenotype From a Racial and Ethnically Diverse US Cohort.
    Circulation. 2023 Nov 16. doi: 10.1161/CIRCULATIONAHA.123.064566.
    >> Share

    October 2023
  12. WIEGMAN A, Greber-Platzer S, Ali S, Doortje Reijman M, et al
    Evinacumab for Pediatric Patients With Homozygous Familial Hypercholesterolemia.
    Circulation. 2023 Oct 20. doi: 10.1161/CIRCULATIONAHA.123.065529.
    >> Share

  13. RAAL F, Durst R, Bi R, Talloczy Z, et al
    Efficacy, Safety, and Tolerability of Inclisiran in Patients With Homozygous Familial Hypercholesterolemia: Results From the ORION-5 Randomized Clinical Trial.
    Circulation. 2023 Oct 18. doi: 10.1161/CIRCULATIONAHA.122.063460.
    >> Share

    September 2023
  14. ALDANA-BITAR J, Karlsberg RP, Budoff MJ
    Letter by Aldana-Bitar et al Regarding Article, "Alirocumab and Coronary Atherosclerosis in Asymptomatic Patients With Familial Hypercholesterolemia: The ARCHITECT Study".
    Circulation. 2023;148:1057.
    >> Share

  15. PEREZ DE ISLA L, Saltijeral Cerezo A, Mata P
    Response by Perez de Isla et al to Letter Regarding Article, "Alirocumab and Coronary Atherosclerosis in Asymptomatic Patients With Familial Hypercholesterolemia: The ARCHITECT Study".
    Circulation. 2023;148:1059-1060.
    >> Share

  16. LONG X, Jiang M
    Letter by Long and Jiang Regarding Article, "Alirocumab and Coronary Atherosclerosis in Asymptomatic Patients With Familial Hypercholesterolemia: The ARCHITECT Study".
    Circulation. 2023;148:1058.
    >> Share

    July 2023
  17. JOHNS DG, Campeau LC, Banka P, Bautmans A, et al
    Orally Bioavailable Macrocyclic Peptide That Inhibits Binding of PCSK9 to the Low Density Lipoprotein Receptor.
    Circulation. 2023;148:144-158.
    >> Share

    May 2023
  18. ZHANG Y, Dron JS, Bellows BK, Khera AV, et al
    Association of Severe Hypercholesterolemia and Familial Hypercholesterolemia Genotype With Risk of Coronary Heart Disease.
    Circulation. 2023;147:1556-1559.
    >> Share

    April 2023
  19. PEREZ DE ISLA L, Diaz-Diaz JL, Romero MJ, Muniz-Grijalvo O, et al
    Alirocumab and Coronary Atherosclerosis in Asymptomatic Patients with Familial Hypercholesterolemia: The ARCHITECT Study.
    Circulation. 2023 Apr 3. doi: 10.1161/CIRCULATIONAHA.122.062557.
    >> Share

    February 2023
  20. PAN C, Herrero-Fernandez B, Borja Almarcha C, Gomez Bris R, et al
    Time-Restricted Feeding Enhances Early Atherosclerosis in Hypercholesterolemic Mice.
    Circulation. 2023;147:774-777.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016